After six years, three failed trials, and one near acquisition, it stood poised on the edge of clinical success. A first in class therapy with blockbuster potential. The CEO had cleared her calendar. The head of R&D was smiling for the first time in months. Investors were circling back. On a Thursday afternoon, quietly and invisibly, something else happened. A junior biostatistician clicked on what looked like a standard login prompt. It was fake. By the time IT noticed unusual outbound traffic, the damage was already underway. Encrypted trial data stored in a poorly segmented cloud repository had been siphoned off. Not all of it, but enough.
The intellectual property was exposed. Competitors knew too much. The edge was gone.
Pharma and Biotech
In pharma and biotech, the science often races ahead of the systems that protect it.
Brilliant research teams operate in digital environments that resemble patchwork quilts.
Legacy ERP systems from over a decade ago. Cloud file sharing tools loosely connected to secure lab networks. Third party vendors holding outdated credentials and “temporary” access that becomes permanent. In an industry where a single discovery can be worth billions, this is not just inefficient. It is dangerous.
Value in the Age of Precision Medicine
The value is not only in the molecule. It is in everything around it.
In the biotech gold rush, IP theft is not theoretical. It is organised, funded, and highly targeted.
Legacy ERP systems from over a decade ago. Cloud file sharing tools loosely connected to secure lab networks. Third party vendors holding outdated credentials and “temporary” access that becomes permanent. In an industry where a single discovery can be worth billions, this is not just inefficient. It is dangerous.
That means role-based access for everyone, everywhere. Auditable data sharing with CROs and CMOs.
Segmentation of high value digital assets just as you segment high value lab equipment.
Zero trust network designs that treat every click as a possible breach.
Because if the molecule is ready but the network is not, the market will not wait.
We protect high value research environments so that your breakthrough is yours alone.
We design secure data flows for trial data, research findings, and regulatory documents, ensuring they remain confidential and intact.
We audit cloud repositories, file sharing systems, and vendor access to prevent poorly segmented storage or lingering credentials from becoming entry points.
We apply least privilege access across teams, vendors, and devices, reducing the risk of credential misuse.
We contain breaches quickly, investigate their source, and recover critical data where possible, minimising operational disruption.
We equip scientific teams with practical security skills so that one mistaken click does not compromise years of work.
We ensure systems meet the security requirements of regulatory bodies such as the FDA, EMA, and local data protection authorities.
When you work with us, you gain more than a cybersecurity service. You gain a strategic sentinel committed to your resilience.
Powered by AlexSta CyberSecurity AG